Dysregulation of miRNA expression and excitation in MEF2C autism patient hiPSC-neurons and cerebral organoids
Open Access
- 30 September 2024
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (4) , 1479-1496
Abstract
MEF2C is a critical transcription factor in neurodevelopment, whose loss-of-function mutation in humans results in MEF2C haploinsufficiency syndrome (MHS), a severe form of autism spectrum disorder (ASD)/intellectual disability (ID). Despite prior animal studies of MEF2C heterozygosity to mimic MHS, MHS-specific mutations have not been investigated previously, particularly in a human context as hiPSCs afford. Here, for the first time, we use patient hiPSC-derived cerebrocortical neurons and cerebral organoids to characterize MHS deficits. Unexpectedly, we found that decreased neurogenesis was accompanied by activation of a micro-(mi)RNA-mediated gliogenesis pathway. We also demonstrate network-level hyperexcitability in MHS neurons, as evidenced by excessive synaptic and extrasynaptic activity contributing to excitatory/inhibitory (E/I) imbalance. Notably, the predominantly extrasynaptic (e)NMDA receptor antagonist, NitroSynapsin, corrects this aberrant electrical activity associated with abnormal phenotypes. During neurodevelopment, MEF2C regulates many ASD-associated gene networks, suggesting that treatment of MHS deficits may possibly help other forms of ASD as well.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R35 AG071734, RF1 AG057409, R01 AG056259, R01 DA048882, R01 NS086890, DP1 DA041722)
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | National Institutes of Health
- California Institute for Regenerative Medicine (DISC2-11070)
- Autism Speaks (postdoctoral fellowship grant #11721)
This publication has 91 references indexed in Scilit:
- Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathwaysNature Neuroscience, 2002
- Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosisProceedings of the National Academy of Sciences, 2002
- Control of Synapse Number by GliaScience, 2001
- Neuronal Activity-Dependent Cell Survival Mediated by Transcription Factor MEF2Science, 1999
- Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturationJournal of Neuroscience, 1995
- Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.Proceedings of the National Academy of Sciences, 1993
- MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex.Proceedings of the National Academy of Sciences, 1993
- Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.Genes & Development, 1992
- Human SRF-related proteins: DNA-binding properties and potential regulatory targets.Genes & Development, 1991
- A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes.Molecular and Cellular Biology, 1989